ORIENT BIO Inc. (KRX:002630)
South Korea flag South Korea · Delayed Price · Currency is KRW
840.00
-33.00 (-3.78%)
Sep 1, 2026, 3:30 PM KST

ORIENT BIO Balance Sheet

Millions KRW. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Cash & Equivalents
11,60210,9402,3509,17024,43819,010
Short-Term Investments
80080080180110,811811
Cash & Short-Term Investments
12,40211,7403,1519,97135,24919,821
Cash Growth
91.92%272.61%-68.40%-71.71%77.84%114.03%
Accounts Receivable
10,4957,0179,4066,72117,79715,729
Other Receivables
1,6201,330672.1297.793,7314,001
Receivables
13,6739,41610,8877,11923,33920,942
Inventory
7,5005,9288,10210,01131,25528,634
Prepaid Expenses
-360.2841.52---
Other Current Assets
6,2581,6161,5485,2356,0227,937
Total Current Assets
39,83429,06023,72932,33695,86577,333
Property, Plant & Equipment
30,93631,32140,24241,66961,91154,853
Long-Term Investments
5,5755,6521,7595,8041,087795.68
Goodwill
-0007,98810,077
Other Intangible Assets
467.85274.53285.6253.37745.98893.3
Long-Term Deferred Charges
-2001,9232,3931,8842,539
Other Long-Term Assets
2,3542,048813.02922.1815,66815,490
Total Assets
82,13071,51975,93984,089190,031165,876

Liabilities

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Accounts Payable
1,091759.97837.39639.1811,44310,426
Accrued Expenses
-370.14316.26285.76684.84922.62
Short-Term Debt
8,1904,9275,0375,94151,61824,212
Current Portion of Long-Term Debt
-1,54048.92,259296.317,063
Current Portion of Leases
939.27544.45687.15---
Current Income Taxes Payable
----13.2413.39
Other Current Liabilities
11,8987,0896,6075,79326,4244,023
Total Current Liabilities
22,11915,23013,53314,91890,47956,661
Long-Term Debt
1,230-1,54048.912,23310,423
Long-Term Leases
301.461,0952,280---
Pension & Post-Retirement Benefits
5,5015,3404,8326,0357,1187,390
Other Long-Term Liabilities
154.51,3081,196440.31276.71207.41
Total Liabilities
29,30622,97323,38121,443110,10774,681

Shareholders' Equity

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Common Stock
59,29259,28650,899114,26881,57380,530
Additional Paid-In Capital
8,8348,8188,19211,1399,12916,844
Retained Earnings
-16,211-19,731-7,492-61,338-39,140-34,935
Treasury Stock
-10.02-10.02-10.02---
Comprehensive Income & Other
919.54182.11967.74718.661,1621,112
Total Common Equity
52,82448,54552,55864,78752,72463,551
Minority Interest
-0.270.15-2,14127,20027,643
Shareholders' Equity
52,82448,54552,55862,64679,92391,195
Total Liabilities & Equity
82,13071,51975,93984,089190,031165,876

Additional Metrics

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Total Debt
10,6618,1079,5938,24964,14751,698
Net Cash (Debt)
1,7413,633-6,4421,722-28,898-31,877
Net Cash Growth
------
Net Cash Per Share
29.3764.18-124.8344.21-804.86-906.41
Filing Date Shares Outstanding
59.2859.2850.8950.8936.3335.87
Total Common Shares Outstanding
59.2859.2850.8950.8936.3335.87
Working Capital
17,71513,83010,19617,4175,38620,672
Book Value Per Share
891.03818.931032.731272.961451.131771.80
Tangible Book Value
52,35648,27052,27264,53443,98952,581
Tangible Book Value Per Share
883.14814.301027.121267.981210.741465.94
Land
-3,2563,3593,2616,7285,501
Buildings
-28,80330,43423,50932,02224,023
Machinery
-4,7964,8221,7988,8539,154
Construction In Progress
-650.922,9686,9486,6905,585